1,480 results on '"Crane, Christopher"'
Search Results
202. Results of Surgical Salvage after Failed Chemoradiation Therapy for Epidermoid Carcinoma of the Anal Canal
203. Magnetic Resonance Guided Radiation Therapy for Pancreatic Adenocarcinoma, Advantages, Challenges, Current Approaches, and Future Directions
204. Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy
205. Preoperative and adjuvant treatment of localized rectal cancer
206. Outcome After Curative Resection for Locally Recurrent Rectal Cancer
207. Delayed Recovery after Pancreaticoduodenectomy: A Major Factor Impairing the Delivery of Adjuvant Therapy?
208. Patterns of Self-Reported Symptoms in Pancreatic Cancer Patients Receiving Chemoradiation
209. Future Chemoradiation Strategies in Pancreatic Cancer
210. Borderline resectable pancreatic cancer
211. Chemoradiotherapy for gastrointestinal cancers
212. State authority in siting of liquefied natural gas import terminals.
213. The rate and risk of secondary pelvic malignancies (SPM) in patients treated with definitive radiation for locally advanced rectal cancer.
214. Deep‐learning‐based image registration and automatic segmentation of organs‐at‐risk in cone‐beam CT scans from high‐dose radiation treatment of pancreatic cancer
215. Magnetic Resonance Guided Radiation Therapy for Pancreatic Adenocarcinoma, Advantages, Challenges, Current Approaches, and Future Directions
216. Association of Ablative Radiation Therapy With Survival Among Patients With Inoperable Pancreatic Cancer
217. Empiric antifungals do not decrease the risk for organ space infection in patients with perforated peptic ulcer
218. In Defense of TNT: A Dynamite Strategy
219. Magnetic Resonance Imaging-Guided Adaptive Radiotherapy for Colorectal Liver Metastases
220. A Survey of the Regulatory Requirements for the Waiver of In Vivo Bioequivalence Studies of Generic Products in Certain Dosage Forms by Participating Regulators and Organisations of the International Pharmaceutical Regulators Programme
221. Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy
222. Pancreaticoduodenectomy with vascular resection: margin status and survival duration
223. Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma
224. Processes of Care in the Multidisciplinary Treatment of Gastric Cancer: Results of a RAND/UCLA Expert Panel
225. 77 - Cáncer de hígado y de vías biliares
226. 77 - Liver and Bile Duct Cancer
227. Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy
228. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal
229. Ghrelin Restoration of Function In Vitro in Somatotropes from Male Mice Lacking the Janus Kinase (JAK)-Binding Site of the Leptin Receptor
230. Somatotropes Lacking Leptin Receptors Secrete Less Growth Hormone (GH) and Cannot Be Restored or Rescued,In Vitro, by Growth Hormone-Releasing Hormone (GHRH)
231. Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases
232. Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head
233. Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration
234. WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment
235. The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer
236. The optimization of dose delivery for intraoperative high-dose-rate radiation therapy using curved HAM applicators
237. Current Approaches and Future Strategies for Pancreatic Carcinoma
238. Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
239. Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: A predictor for patient outcome
240. Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair–proficient Metastatic Colorectal Cancer
241. Impact of Diabetes and Insulin Use on Prognosis in Patients With Resected Pancreatic Cancer: An Ancillary Analysis of NRG Oncology RTOG 9704
242. Challenges in the Study of Adjuvant Chemoradiation After Pancreaticoduodenectomy
243. Number of Lymph Nodes Examined And Prognosis Among Pathologically Lymph Node-Negative Patients After Preoperative Chemoradiation Therapy for Rectal Adenocarcinoma†
244. The Somatotrope as a Metabolic Sensor: Deletion of Leptin Receptors Causes Obesity
245. Pursuit of the Abscopal Effect
246. Trials of locoregional therapies inspired by SABR-COMET
247. Metastatic Pancreatic Cancer: ASCO Guideline Update
248. Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy
249. Impact of varying air cavity on planning dosimetry for rectum patients treated on a 1.5 T hybrid MR‐linac system
250. Trastuzumab with trimodality treatment for esophageal adenocarcinoma with HER2 overexpression: NRG Oncology/RTOG 1010.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.